Kush Parmar

Filings by Kush Parmar span 4 companies, the busiest being Entrada Therapeutics, Inc., Rallybio Corp and Akouos, Inc. Between 28 July 2021 and 10 August 2026, the trades on record add up to 16 filings.

The open-market record consists of 13 sales worth €11.2M, with no purchase. In 2026 alone, the filings show no purchases and 5 sales.

Most recently, on 10 August 2026, the filings show an open-market sale worth €311k in Entrada Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.